Sex Differences in Mortality and Receipt of Kidney Replacement Therapy Among Adults With Stage 5 Chronic Kidney Disease

Further Publications Urology

Chronic kidney disease

Lancet

Herrington WG, Judge PK, Grams ME, Wanner C

doi: 10.1016/S0140-6736(25)01942-7

Further Publications Urology

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

Lancet

Heerspink HJL, Cardona JF, Jolly S, Pergola PE, de Sousa-Amorim E, Eriksson AL, Fredholm M, Gasparyan SB, Guzman NJ, Hartleib-Geschwindner J, Jiang Y, Leonsson-Zachrisson M, Mark PB, MIRO-CKD study investigators

doi: 10.1016/S0140-6736(25)02014-8

Further Publications Urology

Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment

Adv Ther

Rognoni C, Pohlmeier R, Tarricone R

doi: 10.1007/s12325-025-03186-8

Further Publications Urology

Dialysis Transition Patterns of Chronic Kidney Disease Patients With and Without Heart Failure

Mayo Clin Proc

Flagg ME, Bhandari SK, Pak KJ, Zhou H, Shaw SF, Shi JM, Rhee CM, Broder BI, Sim JJ

doi: 10.1016/j.mayocp.2024.11.029

Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia Increases Long-term Chronic Kidney Disease Risk

Mayo Clin Proc

Ouyang C, Zhou L, Liu J, Wang L, Lu Y

doi: 10.1016/j.mayocp.2024.11.024

Further Publications Urology

Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan

Adv Ther

Nangaku M, Sasaki K, Bi J, Ueta K, Nishimura K, Hashimoto T, Hata M

doi: 10.1007/s12325-025-03272-x

Further Publications Urology

Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review

Adv Ther

Wanner C, Zhao MH, Amin AN, De Nicola L, Sauer AJ, Allum AM, Aranda U, Nam YS, Butler J

doi: 10.1007/s12325-025-03228-1

Further Publications Urology

Association between testosterone replacement therapy and cardiovascular events in men: a retrospective propensity-weighted analysis

J Sex Med

Bal DS, Fidel MG, Panchendrabose K, Mann U, Brar R, Patel P

doi: 10.1093/jsxmed/qdaf306

Further Publications Urology

Dermatological adverse effects of testosterone replacement therapy: a scoping review of the literature

Sex Med Rev

Abou Chawareb E, Campos L, Savio L, Hartman-Kenzler J, Mahdi M, Hammad MAM, Yafi FA

doi: 10.1093/sxmrev/qeaf061

Related content

Chronic kidney disease

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment

Dialysis Transition Patterns of Chronic Kidney Disease Patients With and Without Heart Failure

Benign Prostatic Hyperplasia Increases Long-term Chronic Kidney Disease Risk

Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan

Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review

Association between testosterone replacement therapy and cardiovascular events in men: a retrospective propensity-weighted analysis

Dermatological adverse effects of testosterone replacement therapy: a scoping review of the literature